The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
The human phospholamban Arg14-deletion mutant localizes to plasma membrane and interacts with the Na/K-ATPase
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent studies, however, show that PLN phosphorylation by PKA-C is significantly hindered in R14del transgenic mice (∼7% of WT levels), causing Ca2+ mishandling and progression of DCM (13).”
From Dysfunctional conformational dynamics of protein kinase A induced by a lethal mutant of phospholamban hinder phosphorylation (2015) · cites this paper as [13]
In the citing paper
“the fight or flight mechanism, which results in increased PKA-C activity and decreased SERCA inhibition, is severely impaired by the slow phosphorylation of , affecting Ca2+ transients and leading to DCM (10, 13).”
From Dysfunctional conformational dynamics of protein kinase A induced by a lethal mutant of phospholamban hinder phosphorylation (2015) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SERCA2a in Heart Failure: Role and Therapeutic Prospects
Gianni, D., Chan, J., Gwathmey, J. K., del Monte, F., & Hajjar, R. J. (2005) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-005-9474-z · Cited by 65 · cited 1×
“However, the response of the heart to these diverse events indicates that only a few molecules are critical for instigating myocyte malfunction [3].”
BackgroundThe enhanced contractility of the phospholamban-deficient mouse heart persists with aging
Slack, J. P., Grupp, I. L., Dash, R., Holder, D., Schmidt, A., Gerst, M. J., Tamura, T., Tilgmann, C., James, P. F., Johnson, R., et al. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1370 · Cited by 64
Self-citation
Research works printed but not linked: 43
- Cohn, 1997, Current concepts in the treatment of congestive heart failure, Cardiology, 88, 2, 10.1159/000177477 · DOI
- Brini, 2009, Calcium pumps in health and disease, Physiol Rev, 89, 1341, 10.1152/physrev.00032.2008 · DOI · Paper page
- Bers, 2008, Calcium cycling and signaling in cardiac myocytes, Annu Rev Physiol, 70, 23, 10.1146/annurev.physiol.70.113006.100455 · DOI · Paper page
- MacLennan, 2003, Phospholamban: a crucial regulator of cardiac contractility, Nat Rev Mol Cell Biol, 4, 566, 10.1038/nrm1151 · DOI · Paper page
- Brittsan, 2000, Phospholamban and cardiac contractile function, J Mol Cell Cardiol, 32, 2131, 10.1006/jmcc.2000.1270 · DOI · Paper page
- Ke, 2008, Regulation of cardiac excitation and contraction by p21 activated kinase-1, Prog Biophys Mol Biol, 98, 238, 10.1016/j.pbiomolbio.2009.01.007 · DOI
- Koss, 1996, Phospholamban: a prominent regulator of myocardial contractility, Circ Res, 79, 1059, 10.1161/01.RES.79.6.1059 · DOI · Paper page
- Simmerman, 1998, Phospholamban: protein structure, mechanism of action, and role in cardiac function, Physiol Rev, 78, 921, 10.1152/physrev.1998.78.4.921 · DOI · Paper page
- Brittsan, 2003, Chronic SR Ca2+-ATPase inhibition causes adaptive changes in cellular Ca2+ transport, Circ Res, 92, 769, 10.1161/01.RES.0000066661.49920.59 · DOI
- Tada, 1983, Effects of phospholamban phosphorylation catalyzed by adenosine 3′:5′-monophosphate and calmodulin-dependent protein kinases on calcium transport ATPase of cardiac sarcoplasmic reticulum, J Mol Cell Cardiol, 15, 335, 10.1016/0022-2828(83)91345-7 · doi:10.1016/0022-2828(83)91345-7
- Kranias, 1985, Regulation of Ca2+ transport by cyclic 3′,5′-AMP-dependent and calcium-calmodulin-dependent phosphorylation of cardiac sarcoplasmic reticulum, Biochim Biophys Acta, 844, 193, 10.1016/0167-4889(85)90090-4 · DOI
- Luo, 1996, Phospholamban gene dosage effects in the mammalian heart, Circ Res, 78, 839, 10.1161/01.RES.78.5.839 · DOI
- Kadambi, 1996, Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice, J Clin Invest, 97, 533, 10.1172/JCI118446 · DOI · Paper page
- Haghighi, 2006, A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy, Proc Natl Acad Sci U S A, 103, 1388, 10.1073/pnas.0510519103 · DOI · Paper page
- Posch, 2009, Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes, Heart Rhythm, 6, 480, 10.1016/j.hrthm.2009.01.016 · DOI
- Chu, 2000, A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to beta-agonists, J Biol Chem, 275, 38938, 10.1074/jbc.M004079200 · DOI · Paper page
- Brittsan, 2000, Maximal inhibition of SERCA2 Ca2+ affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban, J Biol Chem, 275, 12129, 10.1074/jbc.275.16.12129 · DOI
- Luo, 1994, Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation, Circ Res, 75, 401, 10.1161/01.RES.75.3.401 · DOI · Paper page
- Zhao, 2006, The presence of Lys27 instead of Asn27 in human phospholamban promotes sarcoplasmic reticulum Ca2+-ATPase superinhibition and cardiac remodeling, Circulation, 113, 995, 10.1161/CIRCULATIONAHA.105.583351 · DOI
- Krenz, 2007, Distribution and structure-function relationship of myosin heavy chain isoforms in the adult mouse heart, J Biol Chem, 282, 24057, 10.1074/jbc.M704574200 · DOI
- Pritchard, 2007, Transgenic mice expressing Na+-K+-ATPase in smooth muscle decreases blood pressure, Am J Physiol Heart Circ Physiol, 293, H1172, 10.1152/ajpheart.00279.2007 · DOI
- Bossuyt, 2009, Isoform specificity of the Na/K-ATPase association and regulation by phospholemman, J Biol Chem, 284, 26749, 10.1074/jbc.M109.047357 · DOI
- Robia, 2007, Förster transfer recovery reveals that phospholamban exchanges slowly from pentamers but rapidly from the SERCA regulatory complex, Circ Res, 101, 1123, 10.1161/CIRCRESAHA.107.159947 · DOI
- Despa, 2005, Phospholemman-phosphorylation mediates the ß-adrenergic effects on Na/K pump function in cardiac myocytes, Circ Res, 97, 252, 10.1161/01.RES.0000176532.97731.e5 · DOI · Paper page
- Rubinstein, 2009, Hypercholesterolemia and myocardial function evaluated via tissue Doppler imaging, Cardiovasc Ultrasound, 7, 56, 10.1186/1476-7120-7-56 · DOI
- Chu, 1998, Phospholamban ablation and compensatory responses in the mammalian heart, Ann N Y Acad Sci, 853, 49, 10.1111/j.1749-6632.1998.tb08256.x · DOI
- Menick, 2007, Regulation of Ncx1 gene expression in the normal and hypertrophic heart, Ann N Y Acad Sci, 1099, 195, 10.1196/annals.1387.058 · DOI
- Xu, 2005, The role of p38 in the regulation of Na+-Ca2+ exchanger expression in adult cardiomyocytes, J Mol Cell Cardiol, 38, 735, 10.1016/j.yjmcc.2005.03.002 · DOI
- Eijssen, 2008, Altered myocardial gene expression reveals possible maladaptive processes in heterozygous and homozygous cardiac myosin-binding protein C knockout mice, Genomics, 91, 52, 10.1016/j.ygeno.2007.09.005 · doi:10.1016/j.ygeno.2007.09.005
- Wang, 2007, Mitogen-activated protein kinases in heart development and diseases, Circulation, 116, 1413, 10.1161/CIRCULATIONAHA.106.679589 · DOI · Paper page
- Sharma, 2010, Endoplasmic reticulum protein targeting of phospholamban: a common role for an N-terminal di-arginine motif in ER retention, PLoS One, 5, e11496, 10.1371/journal.pone.0011496 · DOI
- Stenoien, 2007, Cellular trafficking of phospholamban and formation of functional sarcoplasmic reticulum during myocyte differentiation, Am J Physiol Cell Physiol, 292, C2084, 10.1152/ajpcell.00523.2006 · DOI
- Clayton, 2005, The cytoplasmic domains of phospholamban and phospholemman associate with phospholipid membrane surfaces, Biochemistry, 44, 17016, 10.1021/bi0511383 · doi:10.1021/bi0511383
- Shattock, 2009, Phospholemman: its role in normal cardiac physiology and potential as a druggable target in disease, Curr Opin Pharmacol, 9, 160, 10.1016/j.coph.2008.12.015 · DOI
- Sweadner, 2001, Structural similarities of Na, K-ATPase and SERCA, the Ca2+-ATPase of the sarcoplasmic reticulum, Biochem J, 356, 685, 10.1042/0264-6021:3560685 · doi:10.1042/0264-6021:3560685 · Paper page
- Zhang, 2008, Na+/K+-ATPase -mediated signal transduction and Na+/K+-ATPase regulation, Fundam Clin Pharmacol, 22, 615, 10.1111/j.1472-8206.2008.00620.x · DOI
- Aperia, 2007, New roles for an old enzyme: Na, K-ATPase emerges as an interesting drug target, J Intern Med, 261, 44, 10.1111/j.1365-2796.2006.01745.x · DOI · Paper page
- Xie, 2002, Na+/K+-ATPase as a signal transducer, Eur J Biochem, 269, 2434, 10.1046/j.1432-1033.2002.02910.x · DOI · Paper page
- Gan, 2010, Sodium–hydrogen exchange inhibition attenuates glycoside-induced hypertrophy in rat ventricular myocytes, Cardiovasc Res, 85, 79, 10.1093/cvr/cvp283 · doi:10.1093/cvr/cvp283
- Kometiani, 2000, Regulation of Na/K-ATPase b1-subunit gene expression by ouabain and other hypertrophic stimuli in neonatal rat cardiac myocytes, Mol Cell Biochem, 215, 65, 10.1023/A:1026503319387 · DOI
- Dmitrieva, 2002, Cardiotonic steroids: potential endogenous sodium pump ligands with diverse function, Exp Biol Med, 227, 561, 10.1177/153537020222700803 · DOI
- Tian, 2008, The Na-K-ATPase and calcium-signaling microdomains, Physiology, 23, 205, 10.1152/physiol.00008.2008 · DOI
- Pierre, 2007, Ouabain triggers preconditioning through activation of the Na+K+-ATPase signaling cascade in rat hearts, Cardiovasc Res, 73, 488, 10.1016/j.cardiores.2006.11.003 · DOI
Cited by
Modulation of Cardiac Contractility by the Phopholamban/SERCA2a Regulatome
Kranias, E. G., & Hajjar, R. J. (2012) · Circulation Research · doi:10.1161/circresaha.111.259754 · Cited by 532
Self-citationMechanisms of Altered Ca 2+ Handling in Heart Failure
Luo, M., & Anderson, M. E. (2013) · Circulation Research · doi:10.1161/circresaha.113.301651 · Cited by 357
Kim, J., Masterson, L. R., Cembran, A., Verardi, R., Shi, L., Gao, J., Taylor, S. S., & Veglia, G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502299112 · Cited by 45
Vostrikov, V. V., Soller, K. J., Ha, K. N., Gopinath, T., & Veglia, G. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.09.007 · Cited by 29
Metadata
- Authors
- Haghighi, K., Pritchard, T., Bossuyt, J., Waggoner, J. R., Yuan, Q., Fan, G.-C., Osinska, H., Anjak, A., Rubinstein, J., Robbins, J., Bers, D. M., & Kranias, E. G.
- Venue
- Journal of Molecular and Cellular Cardiology
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 52
- Issue
- 3
- Pages
- 773-782
- ISSN
- 0022-2828
- Cited by
- 62
- References
- 2
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- National Institutes of Health (HL-77101, HL-026057, HL-64018, HL-81562)
- Leducq Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The human phospholamban Arg14-deletion mutant localizes to plasma membrane and interacts with the Na/K-ATPase. https://app.cochat.ai/papers/10.1016/j.yjmcc.2011.11.012
- The paper
- Haghighi, K., Pritchard, T., Bossuyt, J., Waggoner, J. R., Yuan, Q., Fan, G.-C., Osinska, H., Anjak, A., Rubinstein, J., Robbins, J., Bers, D. M., & Kranias, E. G. (2012). The human phospholamban Arg14-deletion mutant localizes to plasma membrane and interacts with the Na/K-ATPase. Journal of Molecular and Cellular Cardiology. https://doi.org/10.1016/j.yjmcc.2011.11.012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.